Print Page  |  Close Window

Overview

Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in ... Read More >>

Upcoming Events

There are currently no events scheduled.

Recent News

12/07/18

Covance Xcellerate® Wins Best Technological Development in Clinical Trials (Clinical Sponsor-Focused) at 14th Annual Scrip Awards

12/06/18

Covance Honored with Frost & Sullivan Asia Pacific Award for Fifth Consecutive Year

11/30/18

LabCorp Updates Full-Year 2018 Guidance

LH (Common)
ExchangeNYSE
Price$131.38
Change Stock is Down 2.42
Data as of 12/18/18 2:11 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.